annual CFF:
$364.91M+$343.71M(+1621.34%)Summary
- As of today (September 15, 2025), CNTA annual cash flow from financing activities is $364.91 million, with the most recent change of +$343.71 million (+1621.34%) on December 31, 2024.
- During the last 3 years, CNTA annual CFF has fallen by -$295.16 million (-44.72%).
- CNTA annual CFF is now -44.72% below its all-time high of $660.07 million, reached on December 31, 2021.
Performance
CNTA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$1.63M-$1.46M(-47.27%)Summary
- As of today (September 15, 2025), CNTA quarterly cash flow from financing activities is $1.63 million, with the most recent change of -$1.46 million (-47.27%) on June 1, 2025.
- Over the past year, CNTA quarterly CFF has dropped by -$103.72 million (-98.45%).
- CNTA quarterly CFF is now -99.53% below its all-time high of $345.41 million, reached on June 30, 2021.
Performance
CNTA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$253.79M-$103.72M(-29.01%)Summary
- As of today (September 15, 2025), CNTA TTM cash flow from financing activities is $253.79 million, with the most recent change of -$103.72 million (-29.01%) on June 1, 2025.
- Over the past year, CNTA TTM CFF has increased by +$116.77 million (+85.21%).
- CNTA TTM CFF is now -61.55% below its all-time high of $660.07 million, reached on December 31, 2021.
Performance
CNTA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CNTA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1621.3% | -98.5% | +85.2% |
| 3 y3 years | -44.7% | +2250.4% | +250.9% |
| 5 y5 years | +3952.3% | - | - |
CNTA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.7% | >+9999.0% | -99.3% | +1085.2% | -31.4% | >+9999.0% |
| 5 y | 5-year | -44.7% | >+9999.0% | -99.5% | +252.4% | -61.5% | >+9999.0% |
| alltime | all time | -44.7% | >+9999.0% | -99.5% | +252.4% | -61.5% | >+9999.0% |
CNTA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.63M(-47.3%) | $253.79M(-29.0%) |
| Mar 2025 | - | $3.10M(+107.9%) | $357.52M(-2.0%) |
| Dec 2024 | $364.91M(+1621.3%) | $1.49M(-99.4%) | $364.91M(-1.3%) |
| Sep 2024 | - | $247.57M(+135.0%) | $369.79M(+169.9%) |
| Jun 2024 | - | $105.36M(+904.6%) | $137.03M(+332.5%) |
| Mar 2024 | - | $10.49M(+64.4%) | $31.69M(+49.5%) |
| Dec 2023 | $21.20M(+4541.8%) | $6.38M(-56.9%) | $21.20M(+44.6%) |
| Sep 2023 | - | $14.81M(>+9900.0%) | $14.66M(>+9900.0%) |
| Jun 2023 | - | $12.10K(>+9900.0%) | $66.30K(-46.4%) |
| Mar 2023 | - | $0.00(-100.0%) | $123.70K(-72.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $456.70K(-99.9%) | -$165.80K(-175.4%) | $456.80K(-99.4%) |
| Sep 2022 | - | $220.00K(+216.5%) | $73.62M(+1.8%) |
| Jun 2022 | - | $69.50K(-79.1%) | $72.33M(-82.7%) |
| Mar 2022 | - | $333.10K(-99.5%) | $417.67M(-36.7%) |
| Dec 2021 | $660.07M(>+9900.0%) | $73.00M(-6909.1%) | $660.07M(+12.4%) |
| Sep 2021 | - | -$1.07M(-100.3%) | $587.07M(-0.2%) |
| Jun 2021 | - | $345.41M(+42.3%) | $588.14M(+142.3%) |
| Mar 2021 | - | $242.73M | $242.73M |
| Dec 2020 | $5.05M(-43.9%) | - | - |
| Dec 2019 | $9.01M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual cash flow from financing activities?
- What is the all time high annual CFF for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual CFF year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly CFF year-on-year change?
- What is Centessa Pharmaceuticals plc TTM cash flow from financing activities?
- What is the all time high TTM CFF for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM CFF year-on-year change?
What is Centessa Pharmaceuticals plc annual cash flow from financing activities?
The current annual CFF of CNTA is $364.91M
What is the all time high annual CFF for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual cash flow from financing activities is $660.07M
What is Centessa Pharmaceuticals plc annual CFF year-on-year change?
Over the past year, CNTA annual cash flow from financing activities has changed by +$343.71M (+1621.34%)
What is Centessa Pharmaceuticals plc quarterly cash flow from financing activities?
The current quarterly CFF of CNTA is $1.63M
What is the all time high quarterly CFF for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly cash flow from financing activities is $345.41M
What is Centessa Pharmaceuticals plc quarterly CFF year-on-year change?
Over the past year, CNTA quarterly cash flow from financing activities has changed by -$103.72M (-98.45%)
What is Centessa Pharmaceuticals plc TTM cash flow from financing activities?
The current TTM CFF of CNTA is $253.79M
What is the all time high TTM CFF for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM cash flow from financing activities is $660.07M
What is Centessa Pharmaceuticals plc TTM CFF year-on-year change?
Over the past year, CNTA TTM cash flow from financing activities has changed by +$116.77M (+85.21%)